Application 018709

Type: NDA
Sponsor: APOTHECON

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	CAPOZIDE 25/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
002	CAPOZIDE 25/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
003	CAPOZIDE 50/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
004	CAPOZIDE 50/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N018709-001	CAPOZIDE 25/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12
N018709-002	CAPOZIDE 25/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12
N018709-003	CAPOZIDE 50/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12
N018709-004	CAPOZIDE 50/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`5bbf6a4d5a75…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
Document	Submission type	Date
1044	SUPPL	2009-03-03
1043	SUPPL	2006-05-21